<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/78EBC49D-CEBC-478A-806F-751A99BDE59F"><gtr:id>78EBC49D-CEBC-478A-806F-751A99BDE59F</gtr:id><gtr:firstName>Rachel</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Batterham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F551"><gtr:id>2AA7E1DF-A9D5-46A6-8ED8-78CBC12D5583</gtr:id><gtr:title>The role of Peptide YY in the regulation of energy homeostasis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/551</gtr:grantReference><gtr:abstractText>Obesity is a major cause of illness and death worldwide. Understanding how food intake is controlled may help us to understand the causes of obesity and find new treatments. Peptide YY (PYY) is a hormone that is released into the blood from the gut in response to a meal signalling to the hunger circuits in the brain that food has been eaten. We gave PYY to normal-weight volunteers and found that they ate a third less for 24 hours. We have also discovered that PYY levels are low in obese subjects, suggesting that problems with the PYY system may cause obesity. In overweight volunteers PYY was as equally effective at reducing food intake suggesting that PYY may be a useful drug target.
Before PYY can be used safely as a treatment we need a greater understanding of how PYY is controlled and all its potential effects. We will investigate the factors controlling PYY production and determine why levels are low in obesity. We will identify the exact sites of action of PYY in the brain. We will also examine the effects of both PYY deficiency and chronically increased levels of PYY. These studies may lead to the development of new drugs to treat obesity.</gtr:abstractText><gtr:technicalSummary>Obesity and its associated diseases such as diabetes are major causes of illness and death world-wide. However, there are few effective treatments for this condition. I have shown that peripheral administration of peptide YY3-36 (PYY3-36), a gut-hormone, inhibits food intake and reduces weight gain. PYY3-36 is released into the circulation in response to a meal and acts via NPY-Y2-receptors in the hypothalamic arcuate nucleus, one of the major brain regions regulating food intake and energy expenditure. Recently I have found that PYY levels are low in obese subjects, suggesting that PYY may be involved in the pathogenesis of this condition. Moreover, PYY3-36 administration was effective at reducing food intake in obese subjects hence the PYY system may be a useful target for the treatment of obesity. However, there are many remaining questions regarding the physiology and pathophysiology of the PYY system that need to be understood if this therapeutic potential is to be realised. The outstanding questions will be addressed by the following objectives: 
1. To determine the mechanisms that regulate the synthesis, release and processing of PYY in peripheral tissues:
Studies performed in vivo and in cellular models will determine the regulation of the PYY system, defects that might lead to low levels of PYY in obesity and suggest strategies for elevating endogenous PYY levels.
2. To determine the effects of loss of PYY upon energy homeostasis:
I will generate and analyse in vivo models with global or conditional deletion of PYY and with PYY lacking Y2-receptor specificity. 
3. To determine the CNS pathways that peripheral PYY acts upon and delineate the anatomy and regulation of central PYY neuronal networks:
Neuro-anatomical mapping studies and electrophysiological techniques will determine the sites and mechanisms of action of PYY in the CNS.
4. To determine the effects of chronic elevation of PYY upon energy homeostasis: 
In vivo models over-expressing PYY and chronic administration of PYY3-36 will give insights into the therapeutic potential of PYY.

Studies will involve collaborations with scientists with expertise in molecular biology and in vivo models (Drs H Herzog and D Withers) and in electrophysiology and neuroanatomical studies (Drs M Cowley, K Grove and T Horvath). This programme of research will determine the physiological and pathophysiological roles of the PYY system and determine whether this system is a useful therapeutic target for the treatment of obesity for which there is currently a significant unmet medical need.</gtr:technicalSummary><gtr:fund><gtr:end>2009-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>897139</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media work relatied to Nature paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>D052CEA5-BFD5-4F53-A03A-595EA9454021</gtr:id><gtr:impact>Interviewed by journalists

Increased public awareness of research</gtr:impact><gtr:outcomeId>2BC61A0D6FA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media  work relating to Cell Metabolism Paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>FADA39EB-4BB7-42B7-9756-F6B7AFA37DF1</gtr:id><gtr:impact>Interviewed by several journalists

Increased public awareness of research</gtr:impact><gtr:outcomeId>FBD9E8C7743</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BA Festival of Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>536FC7C6-27F4-4420-9575-0332DFC46493</gtr:id><gtr:impact>Lecture

Media coverage</gtr:impact><gtr:outcomeId>9DF33AF6642</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH Clinical Research and Development Committee</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>114AF439-8585-4F49-A5D2-F767A4435FDD</gtr:id><gtr:outcomeId>CFD664604CA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8FBDB20A-14AA-469F-9234-F461AC35FBF2</gtr:id><gtr:outcomeId>C225391335F0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL Partners AHSC</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>A8E3D29B-1496-42E4-BC65-1063CA00131A</gtr:id><gtr:outcomeId>37CB6696C7C0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE Studentship (GSK)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5A27FEA7-0FCD-43C9-AEF6-CEBED7A691CB</gtr:id><gtr:outcomeId>329B4CBB3600</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>19864651-FDA6-4A23-9C22-C04A1BF34C70</gtr:id><gtr:title>Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f0b88b0251a5088a7fb538c0982cef4"><gtr:id>0f0b88b0251a5088a7fb538c0982cef4</gtr:id><gtr:otherNames>Al-Qassab H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>H6vtzQ9Xbiz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2338E79-26F1-47E9-B59C-006213031C97</gtr:id><gtr:title>Attenuated peptide YY release in obese subjects is associated with reduced satiety.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28a0d9c86754103516b347e3b2e4b71c"><gtr:id>28a0d9c86754103516b347e3b2e4b71c</gtr:id><gtr:otherNames>le Roux CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>43C7A960060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C34A242-B714-4D41-BB70-5A25A2AD6F04</gtr:id><gtr:title>Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/854c2a5c300e6b2002190375bcc291fc"><gtr:id>854c2a5c300e6b2002190375bcc291fc</gtr:id><gtr:otherNames>Karra E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>ZkCtWWHLCjo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAE9A20B-3EDC-4B3C-BA7F-1EDE058D6C56</gtr:id><gtr:title>Peptide YY.</gtr:title><gtr:parentPublicationTitle>Current opinion in endocrinology, diabetes, and obesity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea7bd456583a7151e5fc2172e9107310"><gtr:id>ea7bd456583a7151e5fc2172e9107310</gtr:id><gtr:otherNames>Chandarana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1752-296X</gtr:issn><gtr:outcomeId>1A904F38357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FD7426-C4C3-4DD3-B3F6-4FB06E927802</gtr:id><gtr:title>Gut hormones: implications for the treatment of obesity.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a3b8b69cd52906fb2751a2a757257b"><gtr:id>c5a3b8b69cd52906fb2751a2a757257b</gtr:id><gtr:otherNames>Neary MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>A802BB637B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C70D37ED-179C-4B12-9638-EA6BB9D28617</gtr:id><gtr:title>The role of peptide YY in appetite regulation and obesity.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/854c2a5c300e6b2002190375bcc291fc"><gtr:id>854c2a5c300e6b2002190375bcc291fc</gtr:id><gtr:otherNames>Karra E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>577F080DE3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A55354-7F82-4879-96F2-C87B7BB87D27</gtr:id><gtr:title>Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/631e7e221a0beb9853f27bcc706f1ea9"><gtr:id>631e7e221a0beb9853f27bcc706f1ea9</gtr:id><gtr:otherNames>Cantley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>17D8CA33AEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F39163B-5443-4100-B772-AEE5D6FCC62C</gtr:id><gtr:title>AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5638cc0404e6c478f93da4355c83f817"><gtr:id>5638cc0404e6c478f93da4355c83f817</gtr:id><gtr:otherNames>Claret M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>61C9A1B6ACC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE6A376E-D38F-4D8D-B890-E5F97751533C</gtr:id><gtr:title>The role of gut hormones in the regulation of body weight and energy homeostasis.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/854c2a5c300e6b2002190375bcc291fc"><gtr:id>854c2a5c300e6b2002190375bcc291fc</gtr:id><gtr:otherNames>Karra E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>27688AAF18D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB25410A-1132-4001-B0CF-3AB7B85F6C67</gtr:id><gtr:title>Can glucose make you faint?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>43CB5B90D8E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99B59E25-9400-400F-8626-3895788830DB</gtr:id><gtr:title>Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.</gtr:title><gtr:parentPublicationTitle>Annals of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28a0d9c86754103516b347e3b2e4b71c"><gtr:id>28a0d9c86754103516b347e3b2e4b71c</gtr:id><gtr:otherNames>le Roux CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-4932</gtr:issn><gtr:outcomeId>6D361197CB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F6AE33A-A6E2-4E14-8002-A4D316A46BA2</gtr:id><gtr:title>Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea7bd456583a7151e5fc2172e9107310"><gtr:id>ea7bd456583a7151e5fc2172e9107310</gtr:id><gtr:otherNames>Chandarana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>pm_12540_20_24049729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CF39EAE-3A66-4049-8FE8-6EE9F54B9702</gtr:id><gtr:title>Differential pre-mRNA splicing regulates Nnat isoforms in the hypothalamus after gastric bypass surgery in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72bc95657a242e0b55f306933b43d350"><gtr:id>72bc95657a242e0b55f306933b43d350</gtr:id><gtr:otherNames>Scott WR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12540_20_23527188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F2CF92E-3403-407F-B47D-16F48B26B9B4</gtr:id><gtr:title>Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea7bd456583a7151e5fc2172e9107310"><gtr:id>ea7bd456583a7151e5fc2172e9107310</gtr:id><gtr:otherNames>Chandarana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>326AD878564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9013CD6-65C2-465D-9D4D-3BA8531BC1D4</gtr:id><gtr:title>Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c751c3b3d40edbf575fd15ce4015cab6"><gtr:id>c751c3b3d40edbf575fd15ce4015cab6</gtr:id><gtr:otherNames>Selman C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>V1H3BMMNXRA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C77344-1ADA-41CC-8C92-B16BFB3C4D5D</gtr:id><gtr:title>Gaining new insights into food reward with functional neuroimaging.</gtr:title><gtr:parentPublicationTitle>Forum of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a3b8b69cd52906fb2751a2a757257b"><gtr:id>c5a3b8b69cd52906fb2751a2a757257b</gtr:id><gtr:otherNames>Neary MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0067-8198</gtr:issn><gtr:outcomeId>TSkgqNK8U17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA874E64-D8B5-4F89-8277-D3E46B4EC7D3</gtr:id><gtr:title>Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Regulatory, integrative and comparative physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adcb5562a0187042cff31dc6c7930f91"><gtr:id>adcb5562a0187042cff31dc6c7930f91</gtr:id><gtr:otherNames>Broom DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0363-6119</gtr:issn><gtr:outcomeId>92604582EDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58911094-CB20-4BB9-B180-BC5DFF5EBF64</gtr:id><gtr:title>PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65672b8fc56e6dd458ad58e2becbaed7"><gtr:id>65672b8fc56e6dd458ad58e2becbaed7</gtr:id><gtr:otherNames>Batterham RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>744B86B8065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E65C90B2-1610-4458-99CC-11007C58D97B</gtr:id><gtr:title>Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c751c3b3d40edbf575fd15ce4015cab6"><gtr:id>c751c3b3d40edbf575fd15ce4015cab6</gtr:id><gtr:otherNames>Selman C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5E4B8F47D18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC296A2F-9A31-45D5-B96F-397F47A0D573</gtr:id><gtr:title>Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS).</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6f00352a8f0ce3718423c0b29b79940"><gtr:id>e6f00352a8f0ce3718423c0b29b79940</gtr:id><gtr:otherNames>Tsilchorozidou T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>4235F9271E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAADD545-7BCC-40FD-BD01-F1989DB6D7DD</gtr:id><gtr:title>Metabolic state alters economic decision making under risk in humans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50f59dab1c35737e33d39327a6fba6c4"><gtr:id>50f59dab1c35737e33d39327a6fba6c4</gtr:id><gtr:otherNames>Symmonds M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>NZqopPKoqeR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0317F73E-D721-4ABA-9563-0C23ECE0A9FC</gtr:id><gtr:title>Peptide YY: food for thought.</gtr:title><gtr:parentPublicationTitle>Physiology &amp; behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a3b8b69cd52906fb2751a2a757257b"><gtr:id>c5a3b8b69cd52906fb2751a2a757257b</gtr:id><gtr:otherNames>Neary MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-9384</gtr:issn><gtr:outcomeId>0FBF5B07D18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64E2E020-F28D-4467-806F-4BDC2E05B090</gtr:id><gtr:title>Critical role for peptide YY in protein-mediated satiation and body-weight regulation.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65672b8fc56e6dd458ad58e2becbaed7"><gtr:id>65672b8fc56e6dd458ad58e2becbaed7</gtr:id><gtr:otherNames>Batterham RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>ADAB51668C2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/551</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>